Consolidated statement of cash flows
| in thousand EUR | Notes | 2025 | 2024 | |||
|---|---|---|---|---|---|---|
| Net cash flow from operating activities | ||||||
| Profit/(loss) for the period | –7 605 | –4 873 | ||||
| Income taxes (income)/expenses | 28 | 2 270 | 1 115 | |||
| Interest income | 9 | –1 | –127 | |||
| Interest expenses | 9 | 1 110 | 846 | |||
| Profit/(loss) for the period before interest and taxes | –4 226 | –3 039 | ||||
| Depreciation, amortization and impairment | 8 | 4 239 | 5 933 | |||
| (Profit)/loss on sale of non-current assets | –331 | –140 | ||||
| Share of (profit)/loss of associates | 13 | 498 | 1 749 | |||
| Disposal of financial liabilities | – | –155 | ||||
| Changes in provisions and liabilities to employees | 55 | 188 | ||||
| Change in fair value of biological assets | 11 | –3 150 | –2 465 | |||
| Other non-cash items | 4 600 | –2 260 | ||||
| Operating cash flow before working capital changes | 1 685 | –189 | ||||
| Decrease/(increase) in trade and other receivables | –2 903 | –1 662 | ||||
| Decrease/(increase) in inventories | 1 904 | 2 478 | ||||
| Decrease/(increase) in prepaid expenses | –15 | 702 | ||||
| Increase/(decrease) in trade payables, other liabilities and provisions | 1 997 | –798 | ||||
| Income tax (paid)/received | –1 563 | –1 084 | ||||
| Net cash flow operating activities | 1 105 | –553 |
| in thousand EUR | Notes | 2025 | 2024 | |||
|---|---|---|---|---|---|---|
| Cash flow from investing activities | ||||||
| Purchase of intangible assets | 12 | –39 | –50 | |||
| Proceeds from sale of property, plant and equipment | 462 | 263 | ||||
| Purchase of property, plant and equipment | 10 | –1 282 | –3 285 | |||
| Proceeds from disposal of other non-current assets | 150 | 185 | ||||
| Purchase of other non-current assets | –20 | –251 | ||||
| Increase/(decrease) in recoverable taxes | 13 | – | ||||
| Interests received | 9 | 1 | 127 | |||
| Net cash flow investing activities | –715 | –3 011 | ||||
| Cash flow from financing activities | ||||||
| Transaction costs from capital increase | 371 | –673 | ||||
| Purchase of treasury shares | –51 | – | ||||
| Proceeds from borrowings | 19 | 1 832 | 5 246 | |||
| Repayment of borrowings | 19 | –824 | –258 | |||
| Interests paid | 19 | –948 | –538 | |||
| Interests paid on lease liabilities | 19 / 21 | –110 | –126 | |||
| Repayment of lease liabilities | 19 / 21 | –411 | –318 | |||
| Net cash flow financing activities | –141 | 3 333 | ||||
| Net increase/(decrease) in cash and cash equivalents | 249 | –231 | ||||
| Cash and cash equivalents, at the beginning of the year | 1 341 | 1 648 | ||||
| Increase/(decrease) in cash and cash equivalents | 249 | –231 | ||||
| Translation effect on cash | 2 | –76 | ||||
| Total cash and cash equivalents, at the end of the year | 1 592 | 1 341 |